Cargando…

p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma

BACKGROUND: PERP (p53 apoptosis effector related to PMP-22), a transcriptional target of p53, is downregulated and contributes to the impairment of apoptosis in uveal melanoma (UM). Intriguingly, PERP is not induced in UM despite functional p53. p63, located on chromosome 3, which is characteristica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awais, Raheela, Spiller, David G, White, Michael R H, Paraoan, Luminita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061904/ https://www.ncbi.nlm.nih.gov/pubmed/27584665 http://dx.doi.org/10.1038/bjc.2016.269

Ejemplares similares

PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
por: Davies, L, et al.
Publicado: (2011)

Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis
por: Beaudry, Veronica G., et al.
Publicado: (2010)

The T1799A point mutation is present in posterior uveal melanoma
por: Janssen, C S, et al.
Publicado: (2008)

Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009)

Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer
por: Dusek, Rachel L, et al.
Publicado: (2012)

Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation
por: Pan, D, et al.
Publicado: (2011)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

ER stress-linked autophagy stabilizes apoptosis effector PERP and triggers its co-localization with SERCA2b at ER–plasma membrane junctions
por: McDonnell, Samantha J., et al.
Publicado: (2019)

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005)

Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study
por: Thomas, S, et al.
Publicado: (2012)

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
por: Kalirai, H, et al.
Publicado: (2014)

PERP, a host tetraspanning membrane protein, is required for S almonella‐induced inflammation
por: Hallstrom, Kelly N., et al.
Publicado: (2015)

Mutant p53 mediates survival of breast cancer cells
por: Lim, L Y, et al.
Publicado: (2009)

p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours
por: Dimitriadi, M, et al.
Publicado: (2008)

The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma
por: Bradley, G, et al.
Publicado: (2007)

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
por: Wu, N, et al.
Publicado: (2013)

p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia
por: Groves, M J, et al.
Publicado: (2013)

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
por: Gray-Schopfer, V C, et al.
Publicado: (2006)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma
por: Aryee, D N T, et al.
Publicado: (2013)

High $P_\perp$ Processes
por: Efremov, A V
Publicado: (1977)

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies
por: de Graeff, P, et al.
Publicado: (2006)

The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
por: Voorneveld, P W, et al.
Publicado: (2015)

Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
por: de Graeff, P, et al.
Publicado: (2009)

TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex
por: Madan, E, et al.
Publicado: (2012)

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013)

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation
por: van Miltenburg, M H A M, et al.
Publicado: (2014)

miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop
por: Zhang, Y, et al.
Publicado: (2015)

Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB
por: Antognelli, C, et al.
Publicado: (2014)

Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus
por: Kaneko, K, et al.
Publicado: (2007)

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression
por: Piaton, E, et al.
Publicado: (2005)

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus
por: Sarbia, M, et al.
Publicado: (2007)

DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer
por: Cui, T, et al.
Publicado: (2011)

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
por: Zhang, H, et al.
Publicado: (2013)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53
por: Ou, Wen-Bin, et al.
Publicado: (2016)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
por: Walter, R F H, et al.
Publicado: (2015)

Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells
por: Boudreau, H E, et al.
Publicado: (2014)

TAp63 suppress metastasis via miR-133b in colon cancer cells
por: Lin, C W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q3cp94t59te9r6jg97clin2799